Nanoparticle therapy reprograms tumor immune cells to attack cancer from within [02-01-2026]
Within tumors in the human body, there are immune cells (macrophages) capable of fighting cancer, but they have been unable to perform their roles properly due to suppression by the tumor. A KAIST research team led by Professor Ji-Ho Park of the Department of Bio and Brain Engineering have overcome this limitation by developing a new therapeutic approach that directly converts immune cells inside tumors into anticancer cell therapies.
🚀 The Quantum Catalogue is now live! Discover 100+ key players in #QuantumTech 🌐 Printed edition QUANTUMatter2025 (May 20–23 | Grenoble) Great visibility for companies, investors & collaborators 🗓️ Submit your info by April 21, 2025 💼 Register for free: https://t.co/1PEZKFEb37pic.twitter.com/btZOB6AuHe
— QUANTUM MATTER CONFERENCE (@QuantumConf) April 16, 2025
